Calidi Biotherapeutics (Calidi Biotherapeutics) Ending Cash Position : $0.00 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Ending Cash Position?

Calidi Biotherapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 was $0.00 Mil.

Calidi Biotherapeutics's annual Ending Cash Position declined from Dec. 2021 ($2.24 Mil) to Dec. 2022 ($0.59 Mil) but then increased from Dec. 2022 ($0.59 Mil) to Dec. 2023 ($2.17 Mil).

Calidi Biotherapeutics Ending Cash Position Historical Data

The historical data trend for Calidi Biotherapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Ending Cash Position Chart

Calidi Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

0.42

2.24

0.59

2.17

Calidi Biotherapeutics Quarterly Data
	Dec20	Sep21	Dec21	Sep22	Dec22	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial			-	-	-	-	-

Calidi Biotherapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Calidi Biotherapeutics's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.59	+	1.577
	=	2.17

Calidi Biotherapeutics's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

Calidi Biotherapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037

Website

https://www.calidibio.com

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024